Basic Information
ID: ALA4418817
Type: ADME
Description: Drug metabolism in heparinized pooled human plasma at pH 7.5 assessed as formation of (3-ethoxy-5-(5-((((R)-2-((R)-1-(N-hydroxyformamido)propyl)heptanamido)methyl)carbamoyl) furan-2-yl)phenyl)phosphonic acid at 100 to 2000 ng/ml incubated up to 4 or 24 hrs by by LC-MS/MS analysis
Organism: Homo sapiens
Tissue: Plasma
Activity Charts
Bioactivity
Activity Types for Assay ALA4418817
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 714.75 | 4.96 | 4.96 |
| 672.67 | 4.55 | 4.55 |
| 770.82 | 4.30 | 4.30 |
| 653.67 | 3.96 | 3.96 |
| 728.74 | 3.99 | 3.99 |
| 665.63 | 3.37 | 3.37 |
| 689.67 | 4.60 | 4.60 |
| 742.76 | 3.99 | 3.99 |
| 756.79 | 3.99 | 3.99 |
| 651.69 | 4.28 | 4.28 |
| 715.69 | 3.93 | 3.93 |
| 667.69 | 3.86 | 3.86 |
| 663.55 | 2.38 | 2.38 |
| 744.74 | 4.22 | 4.22 |
| 673.66 | 3.86 | 3.86 |
| 762.80 | 3.99 | 3.99 |
| 687.68 | 4.17 | 4.17 |
| 774.81 | 4.28 | 4.28 |
| 729.76 | 5.29 | 5.29 |
| 735.77 | 4.47 | 4.47 |
| 652.68 | 3.83 | 3.83 |
| 693.77 | 5.59 | 5.59 |
| 717.73 | 5.42 | 5.42 |
| 665.63 | 3.85 | 3.85 |
| 756.79 | 4.95 | 4.95 |
| 671.68 | 4.09 | 4.09 |
| 778.82 | 4.90 | 4.90 |
| 790.85 | 4.30 | 4.30 |
| 753.78 | 5.14 | 5.14 |
| 653.67 | 4.25 | 4.25 |
| 760.83 | 4.76 | 4.76 |
| 638.66 | 3.43 | 3.43 |
| 697.68 | 3.86 | 3.86 |
| 865.81 | 3.91 | 3.91 |
| 760.83 | 4.76 | 4.76 |
| 657.66 | 4.16 | 4.16 |